This cluster is routine — all sales are cashless exercises of in-the-money options with no material dollar value relative to market cap. No action warranted. Monitor for any upcoming earnings or pipeline news that could trigger more meaningful insider activity.
Price Chart
Executive Summary
Three insiders at United Therapeutics, including the CEO and CFO, sold a total of $3.48M in open-market shares over a week, with the CEO alone selling $1.17M. The sales are part of routine option exercises and tax withholding transactions, representing only 0.014% of the company's $24.8B market cap, making them immaterial. No unusual insider behavior or catalyst is evident.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,067 shares for ~$1.17M across three days (Apr 22-27), all tied to option exercises.
- CFO James Edgemond sold 1,996 shares for ~$1.13M across two days (Apr 23 & 27), all tied to option exercises.
- Director Christopher Patusky sold 2,910 shares for $1.66M on Apr 24, tied to option exercises.
- Total open-market sales: $3.48M, or 0.014% of UTHR's $24.8B market cap.
- All sales were preceded by same-day option exercises at strike prices of $101.80-$146.03, indicating routine cashless exercises.
- No open-market purchases were made by any insider during the cluster window.
Financial Impact
Total insider sales of $3.48M, representing 0.014% of market cap — trivial.
Risk Factors
- No material risk identified from this insider activity.
- If future clusters show a step-change in dollar volume or involve multiple C-suite members selling without option exercises, that would be a red flag.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1777413876758 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access